Concepedia

Lena Klopp‐Schulze

LK

Statistics

Publications

10

Citations

278

H-Index

10

Active since

2017

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Ono Pharmaceutical (United States)

Freie Universität Berlin

Merck Serono S.p.A. (Italy)

KU Leuven

Lena Klopp‐Schulze is an author at Merck KGaA, Darmstadt (Germany) specializing in pharmacology, pharmacy, and pharmacokinetic modeling.

ORCID

Publications per year

2017–2025

10

Publications

10

Perspectives on Model‐Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations

Franziska Kluwe, Robin Michelet, Anna Mueller‐Schoell et al. · Clinical Pharmacology & Therapeutics · 2020 · 66 citations · Full text

, , +17

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8

Andreas Port, Jamie Shaw, Lena Klopp‐Schulze et al. · Pharmacology Research & Perspectives · 2021 · 54 citations · Full text

, , +10

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

Lena Klopp‐Schulze, Anna Mueller‐Schoell, Patrick Neven et al. · Frontiers in Pharmacology · 2020 · 28 citations · Full text

, , +17

Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach

Anna Mueller‐Schoell, Lena Klopp‐Schulze, Werner Schroth et al. · Clinical Pharmacology & Therapeutics · 2020 · 28 citations · Full text

, , +17

Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients

Lena Klopp‐Schulze, Markus Joerger, Sebastian G. Wicha et al. · Clinical Pharmacokinetics · 2017 · 22 citations

, , +16

1–5 of 10